Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
233 Leser
Artikel bewerten:
(1)

Copenhagen Infrastructure Partners launches 800MW green hydrogen project in Northern Germany

Finanznachrichten News

Copenhagen Infrastructure Partners and Friesen Elektra Green Energy AG have launched project Anker, a green hydrogen production facility in Sande, Lower Saxony, Germany

COPENHAGEN, Denmark , Jan. 15, 2025 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Partners (CIP), through its Energy Transition Fund (CI ETF I), and Friesen Elektra Green Energy AG (Friesen Elektra) have initiated project Anker, a green hydrogen production facility in Sande, Germany. The project is scheduled to have an electrolysis capacity of 400 MW with plans to expand capacity to 800 MW at a later stage.

Project Anker is strategically located near Wilhelmshaven, an important energy and industrial hub, and near the future German hydrogen core network. It is projected to produce 80,000 tons of green hydrogen annually which will benefit key German industries, including steel and chemicals, as well as the transport sector. The project will bolster the regional economy in Lower Saxony by creating new jobs, growth and fostering active community engagement.

Project Anker will be powered by renewable energy from the grid, supported by offshore and onshore wind, as well as solar energy. By substituting fossil fuels with green hydrogen, the project can reduce CO2 emissions by up to 2.4 million tons annually, equivalent to the emissions of approximately 340,000 households.

"Project Anker has the potential to make an important contribution to Germany's journey towards a carbon-neutral future. At CIP, we continue to see a large potential in green hydrogen despite slower than expected market development and we remain committed to investments in large-scale renewable infrastructure solutions to decarbonize energy-intensive industries. We look very much forward to bring the project to realization together with our new partners at Friesen Elektra and to a constructive collaboration with the German authorities." said Felix Pahl, Partner at CIP

"We are delighted to welcome CIP and its highly skilled, experienced team as a strategic investor and development partner in our Hydrogen Park Friesland. This collaboration is a major step towards creating one of Germany's premier hydrogen production sites. Together, we aim to accelerate the energy transition and advance decarbonization by leveraging our combined strengths and expertise," said Christian Gätje, CFO of Friesen Elektra.
CIP's Energy Transition Fund I (CI ETF I) is the largest dedicated greenfield green hydrogen fund worldwide. CI ETF I has built a market leading portfolio of Power-to-X projects, with around 6.5 GW of electrolyser capacity in its development portfolio globally.

About Copenhagen Infrastructure Partners
Founded in 2012, Copenhagen Infrastructure Partners P/S (CIP) today is the world's largest dedicated fund manager within greenfield renewable energy investments and a global leader in offshore wind. The funds managed by CIP focus on investments in offshore and onshore wind, solar PV, biomass and energy-from-waste, transmission and distribution, reserve capacity, storage, advanced bioenergy, and Power-to-X.

CIP manages 12 funds and has to date raised approximately EUR 31 billion for investments in energy and associated infrastructure from more than 180 international institutional investors. CIP has approximately 500 employees and 12 offices around the world. For more information, visit www.cip.com.

For further information, please contact:

E-mail: media@cip.com

Oliver Routhe Skov, Head of Media Relations
Phone: +45 30541227
Email: orsk@cip.com

Thomas Kønig, Partner - Investor Relations
Phone: +45 7070 5151
Email: tkon@cip.com


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.